Properties | Information | |
---|---|---|
PhytoCAT-ID | PhytoCAT-147 | |
Phytochemical name or plant extracts | Helenalin | |
PMID | 25435410 | |
Literature evidence | A recent study used the PLGA-PEG-helenalin complex, and free helenalin, to inhibit the expression of telomerase in the breast cancer cell line. | |
IUPAC name | (3aR,5R,5aR,8aR,9S,9aS)-9-hydroxy-5,8a-dimethyl-1-methylidene-3a,4,5,5a,9,9a-hexahydroazuleno[6,7-b]furan-2,8-dione | |
Phytochemicals’ class or type of plant extracts | Sesquiterpene lactone | |
Source of phytochemicals or plant Extracts | Psilostrophe cooperi | |
Geographical availability | Arizona, California, Mexico Northwest, Nevada, Utah | |
Plant parts | NA | |
Other cancers | Breast cancer | |
Target gene or protein | Telomerase | |
Gene or Protein evidence | This finding has been proved through the decrease of telomerase gene expression by real-time PCR. | |
Target pathways | NA | |
IC50 | 1.3 μM against T47D for 72h | |
Potency | In this study, we demonstrated that the NC-helenalin complex is more effective than free helenalin in inhibiting the growth of breast cancer cells. | |
Cell line/ mice model | T47D | |
Additional information | The nuclear factor-kappaB (NF-kappaB)-DNA binding inhibitor helenalin (20 microM) also prevented induction. | |
PubChem ID | 23205 | |
Additional PMIDs | NA | |
Additional sources of information | https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:212091-2 | |
Safety | NA |